Ovulatory dysfunction occurs in women with endometriosis, yet the mechanisms are unknown. We have shown that endometriotic lesions synthesize and secrete tissue inhibitor of metalloproteinase (TIMP) 1 into the peritoneal cavity in humans and a rat model of endometriosis, where excess TIMP1 localizes in the ovarian theca in endometriosis and modulating peritoneal TIMP1 alters ovarian dynamics. Here, we evaluated whether mechanisms whereby excessive peritoneal fluid TIMP1 nega-tively impacts ovarian function are matrix metalloproteinase (MMP)-dependent and/or MMP-independent actions. Rats were treated with a mutated TIMP1 without MMP inhibitory function (Ala-TIMP1), wild-type TIMP1 (rTIMP1), or PBS. Rats treated with Ala-TIMP1 or rTIMP1 had f...
Matrix metalloproteinases of the stromelysin family are ex-pressed in the human endometrium as a con...
Ovulation involves reorganization of the extracellular matrix of the follicle. This study examines t...
Introduction. The prevalence of endometriosis among reproductive age women is 7–17%; however, these ...
Human and rat endometriotic lesions synthesize and secrete tissue inhibitor of metalloproteinase 1 (...
The cause of reduced fecundity in women with endometriosis is unknown. Expression of matrix metallop...
Title from PDF of title page (University of Missouri--Columbia, viewed on May 21, 2012).The entire t...
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a multi-functional protein expressed in the uter...
The ovary, one of the most active endocrine organs in human body, plays active rather than passive ...
The role of tissue inhibitors of metalloproteinases (TIMPs) in ovarian function has primarily been d...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
(Requests for offprints should be addressed to W C Duncan) Tissue inhibitor of metalloproteinases-1 ...
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are expressed i...
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are expressed i...
Matrix metalloproteinases of the stromelysin family are ex-pressed in the human endometrium as a con...
Ovulation involves reorganization of the extracellular matrix of the follicle. This study examines t...
Introduction. The prevalence of endometriosis among reproductive age women is 7–17%; however, these ...
Human and rat endometriotic lesions synthesize and secrete tissue inhibitor of metalloproteinase 1 (...
The cause of reduced fecundity in women with endometriosis is unknown. Expression of matrix metallop...
Title from PDF of title page (University of Missouri--Columbia, viewed on May 21, 2012).The entire t...
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a multi-functional protein expressed in the uter...
The ovary, one of the most active endocrine organs in human body, plays active rather than passive ...
The role of tissue inhibitors of metalloproteinases (TIMPs) in ovarian function has primarily been d...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
Endometriosis is a condition defined as presence of endometrium outside of the uterine cavity. These...
(Requests for offprints should be addressed to W C Duncan) Tissue inhibitor of metalloproteinases-1 ...
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are expressed i...
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are expressed i...
Matrix metalloproteinases of the stromelysin family are ex-pressed in the human endometrium as a con...
Ovulation involves reorganization of the extracellular matrix of the follicle. This study examines t...
Introduction. The prevalence of endometriosis among reproductive age women is 7–17%; however, these ...